San Carlos, CA, – NuGEN Technologies, Inc. announced the appointment of Nitin Sood as Chief Executive Officer. He succeeds Elizabeth Hutt who recently left to pursue another opportunity. Mr. Sood comes to NuGEN from PerkinElmer, where he served as Vice President and General Manager of their life science instruments business spanning a portfolio of products […]

SAN DIEGO, SAN FRANCISCO and SPRINGFIELD, Va., – Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a collaboration with the University of California, San Francisco (“UCSF”) to develop 3D bioprinted tissues for skeletal disease research. The collaboration has been […]

Copenhagen, – QIAGEN N.V., Company reg. no. 804803778 (“QIAGEN”), published a Recommended Public Conditional Voluntary Offer on 19 April 2016 (the “Offer”) to the shareholders of Exiqon A/S, Company reg. no. (CVR) 18984431 (“Exiqon”). QIAGEN extended the Offer Period, according to the Offer, on 19 May 2016 and on 3 June 2016. QIAGEN has decided […]

Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced its decision to change the offer conditions for the acquisition of shares in Exiqon A/S, reducing the threshold from 90% to 89.20%. All other terms and conditions remain unchanged. In line with the Danish Takeover Order, which requires the extension of an […]

Oxford, UK – Oxford Gene Technology (OGT), The Molecular Genetics Company, has introduced its SureSeq™ FFPE DNA Repair Mix — optimised to repair a broad range of damage in formalin-fixed, paraffin-embedded (FFPE) derived DNA. The mix effectively repairs DNA damage, improving library yields, on-target rates and mean target coverage, while removing fixation and storage artefacts […]

STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, TecDAX), signed an agreement with Sony DADC Austria AG (”Sony DADC”), based in Anif/Salzburg, Austria, to acquire all of the shares of its BioSciences business, Sony DADC BioSciences GmbH (”Sony DADC BioSciences”), which is a wholly-owned subsidiary of Sony DADC. The acquisition is expected to be […]

Munich, Germany, – Fuse-It-mRNA enables immediate mRNA transfer and a highly efficient protein synthesis in difficult-to-transfect cells. With this innovative reagent, ibidi offers an easy and efficient method for endosome-independent mRNA transfer, accompanied by an extremely low cytotoxicity, in primary cells (e.g., neurons or HUVEC) or stem cells. The Fuse-It liposomal carrier, which includes the […]